OBJECTIVE: To examine the therapeutic efficacy of caspase inhibitors in experimental osteoarthritis (OA). METHODS: Experimental OA was induced in rabbits by anterior cruciate ligament transection (ACLT). Rabbits were treated with intraarticular (i.a.) injections of caspase inhibitors 3 times per week starting 1 week postoperatively. Animals were killed 9 weeks after ACLT, for macroscopic, histologic, and immunohistochemical assessment of the knee joints. RESULTS: I.a. administration of the pan-caspase inhibitor Z-VAD-FMK significantly reduced cartilage degradation, as assessed by macroscopic and microscopic criteria. Untreated knees showed large numbers of chondrocytes with active caspase 3 and the p85 fragment of poly(ADP-ribose) polymerase (PARP p85) that is generated during apoptosis. The frequency of cells positive for PARP p85 and active caspase 3 was reduced in Z-VAD-FMK-treated knees. Inhibitors specific for caspase 3 or caspase 8 showed no significant efficacy. Caspase 1 inhibitor and the combination of caspase 3 and caspase 8 inhibitors reduced OA pathology. CONCLUSION: These results provide direct support for a role of cell death in OA pathogenesis. Caspase inhibitors reduced the severity of cartilage lesions in experimental OA, suggesting that they may have disease-modifying activity in human OA.
OBJECTIVE: To examine the therapeutic efficacy of caspase inhibitors in experimental osteoarthritis (OA). METHODS: Experimental OA was induced in rabbits by anterior cruciate ligament transection (ACLT). Rabbits were treated with intraarticular (i.a.) injections of caspase inhibitors 3 times per week starting 1 week postoperatively. Animals were killed 9 weeks after ACLT, for macroscopic, histologic, and immunohistochemical assessment of the knee joints. RESULTS: I.a. administration of the pan-caspase inhibitor Z-VAD-FMK significantly reduced cartilage degradation, as assessed by macroscopic and microscopic criteria. Untreated knees showed large numbers of chondrocytes with active caspase 3 and the p85 fragment of poly(ADP-ribose) polymerase (PARP p85) that is generated during apoptosis. The frequency of cells positive for PARP p85 and active caspase 3 was reduced in Z-VAD-FMK-treated knees. Inhibitors specific for caspase 3 or caspase 8 showed no significant efficacy. Caspase 1 inhibitor and the combination of caspase 3 and caspase 8 inhibitors reduced OA pathology. CONCLUSION: These results provide direct support for a role of cell death in OA pathogenesis. Caspase inhibitors reduced the severity of cartilage lesions in experimental OA, suggesting that they may have disease-modifying activity in human OA.
Authors: James R Pinney; Carmen Taylor; Ryan Doan; Andrew J Burghardt; Xiaojuan Li; Hubert T Kim; C Benjamin Ma; Sharmila Majumdar Journal: Magn Reson Imaging Date: 2011-11-08 Impact factor: 2.546
Authors: Edward D Bonnevie; Michelle L Delco; Lena R Bartell; Naveen Jasty; Itai Cohen; Lisa A Fortier; Lawrence J Bonassar Journal: J Biomech Date: 2018-04-25 Impact factor: 2.712
Authors: Brendan L Roach; Arta Kelmendi-Doko; Elaine C Balutis; Kacey G Marra; Gerard A Ateshian; Clark T Hung Journal: Tissue Eng Part A Date: 2016-03-31 Impact factor: 3.845
Authors: Kimberly A Waller; Ling X Zhang; Khaled A Elsaid; Braden C Fleming; Matthew L Warman; Gregory D Jay Journal: Proc Natl Acad Sci U S A Date: 2013-03-25 Impact factor: 11.205
Authors: Prem Ramakrishnan; Benjamin A Hecht; Douglas R Pedersen; Matthew R Lavery; Jerry Maynard; Joseph A Buckwalter; James A Martin Journal: J Orthop Res Date: 2010-07 Impact factor: 3.494